Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2010 Sep 16;285(47):36794–36803. doi: 10.1074/jbc.M110.167312

Staphylococcal Major Autolysin (Atl) Is Involved in Excretion of Cytoplasmic Proteins*

Linda Pasztor , Anne-Kathrin Ziebandt , Mulugeta Nega , Martin Schlag , Sabine Haase , Mirita Franz-Wachtel §, Johannes Madlung §, Alfred Nordheim §, David E Heinrichs , Friedrich Götz ‡,1
PMCID: PMC2978608  PMID: 20847047

Abstract

Many microorganisms excrete typical cytoplasmic proteins into the culture supernatant. As none of the classical secretion systems appears to be involved, this type of secretion was referred to as “nonclassical protein secretion.” Here, we demonstrate that in Staphylococcus aureus the major autolysin plays a crucial role in release of cytoplasmic proteins. Comparative secretome analysis revealed that in the wild type S. aureus strain, 22 typical cytoplasmic proteins were excreted into the culture supernatant, although in the atl mutant they were significantly decreased. The presence or absence of prophages had little influence on the secretome pattern. In the atl mutant, secondary peptidoglycan hydrolases were increased in the secretome; the corresponding genes were transcriptionally up-regulated suggesting a compensatory mechanism for the atl mutation. Using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a cytoplasmic indicator enzyme, we showed that all clinical isolates tested excreted this protein. In the wall teichoic acid-deficient tagO mutant with its increased autolysis activity, GAPDH was excreted in even higher amounts than in the WT, confirming the importance of autolysis in excretion of cytoplasmic proteins. To answer the question of how discriminatory the excretion of cytoplasmic proteins is, we performed a two-dimensional PAGE of cytoplasmic proteins isolated from WT. Surprisingly, the most abundant proteins in the cytoplasm were not found in the secretome of the WT, suggesting that there exists a selection mechanism in the excretion of cytoplasmic proteins. As the major autolysin binds at the septum site, we assume that the proteins are preferentially released at and during septum formation.

Keywords: Bacteria, Cell Wall, Gel Electrophoresis, Mass Spectrometry (MS), Protein Secretion, Staphylococcus aureus, Cytoplasmic Proteins, Major Autolysin, Supernatant

Introduction

Proteome analyses were carried out in staphylococci to study the expression of proteins under biofilm and anoxic growth conditions (1, 2), growing and nongrowing cells (3), or global regulator mutants such as agr, σB, and clpC (46). In most of the studies cytoplasmic proteins were addressed, and only few were focused on the extracellular proteome or secretome. The latter studies showed that in the culture supernatants of Bacillus subtilis and Staphylococcus aureus, a number of typical cytoplasmic proteins, which lack a signal sequence, were present (5, 7, 8). It is generally assumed that the release of such cytoplasmic proteins is due to cell lysis, although specific export processes for excretion of cytoplasmic proteins could not be excluded.

In B. subtilis, various possibilities have been discussed about how such cytoplasmic proteins could be secreted (8). It was speculated that prophage-encoded holins could form pores in the membrane through which the lytic enzymes of bacteriophages, which usually lack a signal peptide (SP),2 gain access to the cell wall (CW) (9). However, elimination of several prophages from a strain had no effect on the appearance of cytoplasmic proteins in the extracellular proteome (10). Thus, cytoplasmic proteins do not seem to leave the cytoplasm in B. subtilis via prophage-encoded holins, as proposed for Lactococcus lactis (11). Another long held assumption was that they are released by cell lysis; in particular, some of the proteins were highly abundant in the cytoplasmic proteome of B. subtilis (12).

In S. aureus, various specialized protein secretion systems have been described, including the Ess (ESAT-6 secretion system) (13), the TAT secretion system (14), and ATP-binding cassette transporters involved in antibiotic efflux or secretion of peptide antibiotics (15, 16). However, apparently none of these well known secretion machineries appear to be involved in the secretion of cytoplasmic proteins. Because no pattern of specific signal sequences or other peptide motifs could be identified with the proteins present in the culture supernatants, the existence of a novel, “nonclassical protein secretion” mechanism was postulated (17).

Here, we addressed the question of whether prophages and/or autolysins might play a role in excretion of cytoplasmic proteins. For S. aureus, it is well known that cell lysis is caused by induction of prophages, the major autolysin, or by the addition of β-lactam antibiotics. Most clinical S. aureus isolates possess prophages, and many of them carry virulence genes. The staphylococcal strain used in this study, S. aureus SA113, is a derivative of S. aureus NCTC8325, which is lysogenic for the three functional phages φ11, φ12, and φ13 (18). To study the effect of prophages in excretion of cytoplasmic proteins, S. aureus 8325-4, a derivative of NCTC8325 (RN1), is the strain of choice, because it has been UV-cured of all three prophages and is very useful for phage propagation (19).

The other well studied enzyme that is involved in cell lysis in S. aureus and Staphylococcus epidermidis is the major autolysin (Atl). It is the main peptidoglycan hydrolase in staphylococci. It represents a bifunctional protein composed of a propeptide region, an amidase, and an endo-β-N-acetylglucosaminidase domain. Atl is processed to generate two extracellular lytic enzymes, which are noncovalently attached to the staphylococcal cell surface (20, 21). Autolysis is markedly decreased in an atl mutant (22); the major lytic activity resides in the amidase (23, 24). Atl is sec-dependent exported, and it has been shown that wall teichoic acid plays a crucial role in targeting the Atl-derived autolysins to the septum region (22). Atl has various functions; it is involved in the separation of the daughter cells by hydrolyzing the amide bond between N-acetylmuramic acid and l-alanine (23); it acts directly as an adhesin by binding to fibronectin and vitronectin mainly via the peptidoglycan binding domains; it is involved in biofilm formation (21); and finally, atl mutants were attenuated in pathogenesis in an intravascular catheter-associated rat infection model (25).

We show here that the major autolysin (Atl) plays a crucial role in excretion of cytoplasmic proteins, that the excretion of cytoplasmic proteins appears to be a general phenomenon in clinical isolates of S. aureus and also S. epidermidis, and finally, that excretion of proteins is not random. It seems that there is a selection process at work.

EXPERIMENTAL PROCEDURES

Bacterial Strains and Growth Conditions

Bacterial strains used in this study are listed in Table 1. Cells were grown in Basic medium (BM: 10 g of peptone; 5 g of yeast extract; 5 g of NaCl; 1 g of K2HPO4·3H2O; 1 g of glucose; pH 7.2; per liter) or on BM-agar (B-medium supplemented with 15 g of agar per liter). Strain stocks were stored in freeze medium containing 65% (w/v) glycerol at −80 °C. Frozen strains were streaked for isolation onto BM-agar with and without antibiotic for the mutants and WT strains, respectively, and incubated overnight. Antibiotics were used at the following concentrations: spectinomycin 150 μg/ml; chloramphenicol 10 μg/ml, and erythromycin 10 μg/ml. Strains were inoculated from plate cultures into flasks containing B-medium (with or without antibiotic) and incubated overnight (16 h) at 37 °C with rotary aeration of 150 rpm. Overnight cultures were inoculated into fresh B-medium to an A578 nm of 0.1. The ratio of medium volume to flask was maintained at 1:5. The cell suspension was incubated at 37 °C with rotary aeration at 150 rpm.

TABLE 1.

Bacteria used in this study

The abbreviations used are as follows: Spc, spectinomycin; Cm, chloramphenicol; Erm, erythromycin; and superscript r indicates resistance.

Strains Genotypes Refs./Source
S. aureus SA113 rsbU, agr, tcaR 50
S. aureus SA113 Δatl::spc Δatl::spc, Spcr 23
S. aureus SA113 Δatl::spc(pRBatlE) Δatl::spc complemented with pRC14, Spcr, Cmr 51
S. aureus SA113 Δatl::spc(pRB473) Δatl::spc with the empty vector pRB473, Spcr, Cmr This study
S. aureus SA113 ΔtagO::erm ΔtagO::erm, Ermr 52
S. aureus 8325-4 Wild type strain 8325 UV cured of prophages 19
S. aureus SA113 Δspa::erm Δspa::erm, Ermr 38
S. aureus RN1 rsbU, agr 53
S. aureus HG001 rsbU repaired, tcaR 38
S. aureus HG002 rsbU, tcaR repaired 38
S. aureus HG003 HG001 derivative, rsbU and tcaR repaired 38
S. aureus Newman Clinical isolate 54
S. aureus USA300 Clinical isolate 55
S. aureus UAMS-1 Clinical isolate 56
S. aureus COL agr 57
S. carnosus TM300 58
S. epidermidis O-47 Clinical isolate 59
Preparation of Different Protein Fractions for Two-dimensional PAGE

Cells from SA113 and its atl deletion mutant were grown in B-medium as described before, harvested after 8 h of growth, and pelleted by centrifugation at 8000 × g for 30 min at 4 °C. For preparation of the extracellular fraction, supernatant proteins were extracted, pelleted, and dried as described earlier (5). Isolation of the cytoplasmic proteins was described previously (26). Cells were washed and disrupted using glass beads. Cytoplasmic proteins were precipitated, pelleted, washed with 100% ethanol, and dried.

Proteins were redissolved in an appropriate volume of buffer consisting of 8 m urea, 2 m thiourea, 4% CHAPS (w/v), 1% dithiothreitol (DTT), 0.7% Pharmalyte (pH 3–10; GE Healthcare). All chemicals were purchased from Merck in the highest available grade unless stated otherwise. The total soluble protein concentration was measured by the Bradford method (27).

Two-dimensional PAGE

Two-dimensional PAGE was performed as described previously (28, 29). 500 μg of protein were loaded onto commercially available IPG strips (24 cm, pH 3–10 nonlinear or pH 4–7 linear; Bio-Rad) in a Protean IEF cell (Bio-Rad). After rehydration, the voltage was progressively increased to 10,000 V. The strips received about 63 kVh. The maximum current was 50 μA per gel strip. For the second dimension, the equilibrated gel strips were applied to 15% (extracellular fraction) and 12% (intracellular fraction) polyacrylamide gels. A standard molecular weight marker from Anamed (Gross-Biebarau, Germany) was loaded. The resulting protein gels were stained with Colloidal Coomassie “Silver Blue” (0.12% Coomassie G-250, 10% ammonium sulfate, 10% phosphoric acid, and 20% methanol) as described by Candiano et al. (30) and scanned using a flatbed scanner (Powerlook 2100 XL, Umax, Willich, Germany).

Image Analysis

Three independent experiments were performed for each condition having three biological replicates. The three resulting gels of the secretome of the WT SA113 were compared with the gels of the secretome of the atl mutant by image analysis using the Delta2D-software (DECODON, Greifswald, Germany). Protein spots showing significant differences in intensity between WT and mutant secretome were recognized, and their reproducibility of differential representation was confirmed. Protein spots were identified by mass spectrometry.

Liquid Chromatography-Mass Spectrometry (MS) Analysis

Tryptic in-gel digestion and peptide analysis were done as described previously (31), using an Ultimate nanoflow HPLC system (Dionex/LC Packings) coupled to a QSTAR Pulsar i Hybrid QqTOF mass spectrometer (Applied Biosystems/MDS Sciex) equipped with a nanoelectrospray ion source. MS data were searched using the Mascot search engine (Matrix Science, London, UK) against a specialized data base containing the sequence of S. aureus N315; this data base also contained common contaminants as well as reversed versions of the sequences. Data related to the same gel were combined into a single peak list and subsequently processed as combined searches. The software packet MS Quant was used for assigning the resulting sequence information to the respective two-dimensional PAGE signals. Following the approach of MS Quant, peptides were classified into categories. Three groups were formed by applying probability values of different stringency as follows: group A, p < 0.01, score >29; group B, p < 0.05 and p > = 0.01, score >22; and group C. p < 0.1 and p > = 0.05, score >19. The scores corresponded to the mascot ion score for different false-positive probabilities. Protein identification was defined as valid if the sum of all associated peptide scores was greater or equal to the score of group B plus the score of group C, i.e. 41. Furthermore, the observed molecular weight and pI had to be close to the predicted protein apart from protein fragments.

Northern Blot Analyses

The cells of the WT S. aureus SA113, the isogenic atl mutant, and the complemented strain were grown in B-medium as described earlier and were harvested after 3, 6, and 8 h of growth. For isolation of total RNA from S. aureus, the acid-phenol method (32, 33) was used with some modifications as described by Fuchs et al. (1). Digoxigenin-labeled RNA probes of the corresponding genes were prepared by in vitro transcription with T7 RNA polymerase by using a PCR fragment as template (32), which was generated by using chromosomal DNA of S. aureus SA113 and the respective oligonucleotides listed in supplemental Table 1. The reverse oligonucleotides contained the T7 RNA polymerase recognition site sequence at the 5′ end. For Northern blot analyses, equal amounts of total RNA (10 μg for each Northern blot, for spa, hla, and aaa blots only 5 μg of total RNA were loaded) were separated under denaturing conditions in a 1% agarose gel containing 20 mm MOPS, 5 mm sodium acetate, 1 mm EDTA, 1.85% formaldehyde, pH 7.0. The gel was blotted onto a nylon membrane with 20× SSPE (3 m NaCl, 0.2 m NaH2PO4, 0.02 m EDTA, pH 7.4) by using a vacuum blotter. After 4 h of transfer, the RNA was fixed to the membrane by UV cross-linking for 1 min. The membrane was stained with methylene blue to visualize 16 and 23 S rRNA bands to control for successful blotting and the presence of the comparable amounts of total RNA in each lane. The digoxigenin-labeled RNA probes were used for gene-specific hybridization according to the manufacturer's instructions (Roche Applied Science). Hybridization signals were detected using the Lumi-Film chemiluminescent detection film (Roche Applied Science).

Preparation of Protein Extracts for Western Blot Analysis

Cells (Table 1)were grown for 2, 4, 6, 8, 14, 24, and 48 h in B-medium and then pelleted by centrifugation at 5000 rpm for 30 min at 4 °C. Proteins in the supernatant were isolated as described above. The resulting protein pellet was dried and resuspended in an appropriate volume of buffer consisting of 8 m urea and 2 m thiourea. The amount of protein in the samples was determined by the method described by Bradford (27). For determination of GAPDH in the supernatant of different S. aureus WT strains, the cells were pelleted, and the supernatant proteins were concentrated using StrataCleanTM resin (Stratagene, Heidelberg, Germany) prior to gel electrophoresis.

Western Blot Analyses

The same amount of protein per lane was separated on 15% SDS-PAGE according to Schagger and von Jagow (34) and electrophoretically transferred to nitrocellulose membrane (Protran, nitrocellulose membrane, Schleicher & Schuell BA83) (1 h 20 min, 350 mA), buffered in semi-dry transfer buffer using a Trans-Blot SD Semi-Dry Transfer Cell from Bio-Rad). After blotting, the membrane was treated and washed as described previously (35). To block unspecific interactions with protein A, the membrane was incubated for 2 h with 5% goat serum (Sigma) and diluted in TBS buffer containing 0.3% bovine serum albumin (BSA, Carl-Roth, Karlsruhe, Germany). For the detection of GAPDH, the membrane was incubated for 1 h with the specific rabbit polyclonal anti-GapA antibody diluted 1:15,000 in TBS buffer containing 0.3% BSA. Generation of the anti-GapA antibody has been described previously (36). The specific bound anti-GapA was detected by incubation with anti-rabbit alkaline phosphatase-labeled secondary antibody produced in goat (Sigma) diluted 1:20,000 in TBS buffer containing 0.3% BSA. For the chemiluminescent detection, nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate ready-to-use solution (Sigma) was used following the manufacturer's instructions.

Determination of Extracellular Proteases on Casein Plate

Cells of the WT S. aureus SA113, its isogenic atl mutant, and the complemented strain were grown in B-medium agar plate overnight and resuspended in B-medium, and equal amounts of cells in a volume of 5 μl was dropped on a casein plate (B-medium agar plate + 1% milk powder as casein source) and incubated for 18 h at 37 °C.

Definition of Functional Domains of Alternative Peptidoglycan Hydrolase Proteins

For definition of lengths and positions of different domains of the alternative peptidoglycan hydrolases, the publicly available annotation tool from the Sanger Institute was used.

RESULTS

In the Atl Mutant the Amount of Excreted Cytoplasmic Proteins Was Significantly Decreased

It is well known that many bacteria release into the culture supernatant typical cytoplasmic proteins lacking an SP. It is commonly believed that such proteins are released “accidentally” by some unspecific autolysis processes. On the other hand, one cannot exclude that a previously unidentified mechanism underlies this protein excretion. With regard to lytic processes, an obvious mechanism for cell lysis could be induction of prophages or unbalanced autolysis.

To investigate the contribution of lytic processes in release of cytoplasmic proteins, we carried out a comparative secretome (total proteins released to the bacterial culture supernatants) analysis. We compared the secretome of SA113 (NCTC8325 lineage) carrying three prophages (φ11, φ12, and φ13) with two mutants; one was affected in phage lysis and the other in the major autolysin. The two mutants were 8325-4, which is cured of the prophages (19), and SA113 atl mutant, in which the major autolysin gene atl has been deleted (23). The atl deletion and the atl complementing plasmid are illustrated in supplemental Fig. 1. A comparison of the secretome of SA113 with that of 8325-4 revealed virtually no differences in the general protein pattern; the released cytoplasmic proteins were almost the same, indicating that the presence of prophages had no marked influence on release of cytoplasmic proteins. None of the prevailing opinions on the role of prophage in the release of cytoplasmic proteins was therefore relevant, at least with these strains.

However, the secretome pattern of the atl mutant versus WT was drastically altered (Fig. 1B). For better comparison of the protein spots of the two-dimensional PAGE, the gels of SA113 and the atl mutant were overlaid using Delta2D software. Proteins with higher abundance in SA113 are marked in Fig. 1A, and proteins with higher abundance in the atl mutant are marked in Fig. 1B. The most striking result was that the secretome of SA113 contained 22 typical cytoplasmic proteins (Fig. 1, A labeled in blue) in much higher abundance than that of the atl mutant. All these cytoplasmic proteins lack a typical SP and are supposed to be localized in the cytoplasm. Among the excreted cytoplasmic proteins in the SA113 were chaperones, the DNA-dependent RNA polymerase RpoB, proteins which are involved in translation, in glycolysis, TCA cycle, and several other metabolic functions and pathways. They are listed in Table 2.

FIGURE 1.

FIGURE 1.

Differential two-dimensional PAGE of secretomes (A and B) of SA113 and its atl mutant and of the intracellular protein fraction of SA113 (C). Cells were grown in B-medium and harvested after 8 h of growth. 500 μg of proteins were separated by two-dimensional PAGE in a pI range from 3 to 10 or 4 to 7 and stained with Colloidal Commassie “Silver Blue.” Secretome of the WT S. aureus SA113 (green staining of protein spots) and secretome of the atl mutant (red staining of protein spots) were overlaid using Delta2D software. A, proteins with higher abundance in the WT are indicated by arrows; typically cytoplasmic proteins are labeled in blue. B, proteins with higher abundance in the atl mutant are indicated by arrows; proteins with potential peptidoglycan hydrolase activity are labeled in red. C, proteins that were also excreted are labeled in blue; proteins that were not found in the secretome are labeled in black.

TABLE 2.

Proteins more abundant in the secretome of the WT

Superscript F indicates fragment.

Protein Protein name Gene accession no. S. aureus N315 Gene accession no. S. aureus 8325 Molecular mass pI
kDa
Cytosolic proteins without SP
    ClpC Endopeptidase SA0483 00505 91 5.5
    DnaK DnaK protein SA1409 01683 66 4.7
    EF-G/fusA Translational elongation factor G SA0505 00529 77 4.8
    EF-TU Translational elongation factor TU SA0506 00530 43 4.3
    Eno Enolase SA0731 00799 47 4.6
    FbaA Fructose-bisphosphate aldolase SA1927 02366 31 5
    Gap Glyceraldehyde-3-phosphate dehydrogenase SA0727 00795 36 4.9
    GlpD Aerobic glycerol-3-phosphate dehydrogenase SA1142 01278 64.5 8.3
    GroEL GroEL protein SA1836 02254 58 4.6
    IleS Ile-tRNA synthetase SA1036 01159 105 5.2
    LeuS Leucyl-tRNA synthetase SA1579 01875 92 4.9
    Mqo2 Malate:quinone oxidoreductase SA2400 02927 56 6.5
    OdhA 2-Oxoglutarate dehydrogenase E1 SA1245 01418 103 5.5
    PdhB Pyruvate dehydrogenase E1 component β subunit SA0944 01041 35 4.7
    PdhC Dihydrolipoamide S-acetyltransferase component of pyruvate dehydrogenase complex E2 SA0945 01042 46 4.9
    PtsI Phosphoenolpyruvate-protein phosphatase SA0935 01029 63 4.6
    PycA Pyruvate carboxylase SA0963 01064 129 5
    RpoB DNA-directed RNA-polymerase β chain SA0500 00524 133 4.8
    RpsB 30 S ribosomal protein S2 SA1099 01232 29.1 5.4
    SA0829 Hypothetical protein SA0829 00906 33.1 4.8
    SAS074 Conserved hypothetical protein SAS074 02425 10 6
    TrxB Thioredoxin reductase SA0719 00785 34 5.2

Extracellular proteins with SP
    AtlF Autolysin SA0905 00994 Fragment
    AurF Zinc metalloproteinase aureolysin SA2430 02971 Fragment
    Geh Glycerol ester hydrolase SA0309 00300 72.4a 8.9a
    GehF Glycerol ester hydrolase SA0309 00300 Fragment
    Hla α-Hemolysin precursor SA1007 01121 33a 7.9a
    IsaAF Immunodominant antigen A SA2356 02887 Fragment
    LipF Triacylglycerol lipase precursor SA2463 03006 Fragment
    SA0570 Hypothetical protein SA0570 00617 15.9a 9.2a
    SA2437F N-Acetylmuramoyl-l-alanine amidase SA2437 02979 Fragment

Cell wall proteins with SP and sorting sequence
    SdrD Ser-Asp-rich, fibrinogen-binding, bone sialoprotein-binding protein SA0520 00545 144a 4.1a
    Spa Immunoglobulin G-binding protein A precursor SA0107 00069 45.3a 5.2a
    SA0129 Hypothetical protein SA0129 00094 23.6a 9.3a

a Molecular mass and pI values were calculated for the mature protein without SP. For calculation of the theoretical SP, SignalP software was used. The localization of the proteins was predicted by PSORTb.

To answer the question whether only highly expressed cytoplasmic proteins were excreted, we performed a two-dimensional PAGE of cytoplasmic proteins isolated from SA113. In blue were those proteins labeled that were also found in the secretome and in black those proteins that were not found in the secretome (Fig. 1C). As one can see, there are highly abandoned cytoplasmic proteins that were not excreted as follows: Fhs (formyltetrahydrofolate synthetase), GuaB (IMP dehydrogenase, part of a four-gene operon consisting of xpt, pbuX, guaB, and guaA in S. aureus), SA0802 (hypothetical protein, NADH dehydrogenase), KatA (catalase), GlpA (glycerol-3-phosphate dehydrogenase subunit A), PdhD (dihydrolipoamide dehydrogenase component of pyruvate dehydrogenase E3), SucC (succinyl-CoA synthetase, β subunit), or EF-Ts (elongation factor Ts). All these typical cytoplasmic proteins are in very high abundance in the cytoplasm and still not found in the secretome.

Besides the typical cytoplasmic proteins, three CW-anchored proteins (possessing an LPXTG motif) were in higher abundance in the secretome of WT compared with the atl mutant. The CW-anchored proteins were SdrD (Ser-Asp-rich fibrinogen- and bone sialoprotein-binding protein), Spa (immunoglobulin G-binding protein A), and SA0129 (protein with unknown function).

There were also a few secreted proteins (with typically SP) present in larger quantity in the secretome of SA113 compared with the atl mutant. Among them were α-hemolysin (Hla), glycerol ester hydrolase (Geh), and protein SA0570 with unknown function.

Some of the higher abundant proteins in the secretome of SA113 were proteolytically processed, such as Geh, Lip, IsaA, metalloprotease aureolysin (Aur), N-acetylmuramoyl-l-alanine amidase SA2437 (Aly), or of the major autolysin (Atl) itself (Fig. 1A and Table 2). Indeed, SA113 and the complemented atl mutant showed proteolytic activity on casein plates, although the atl mutant does not (Fig. 2). Most likely, the proteolytic activity is due to the Zn2+ metalloprotease, aureolysin, as other protease spots were not found in the secretome.

FIGURE 2.

FIGURE 2.

Determination of extracellular protease activity on casein plate. The cells were diluted in B-medium, and the same amount of cells in a volume of 5 μl was dropped on a casein plate and incubated for 18 h at 37 °C. Protease activity is indicated by a halo.

In the atl Mutant Secondary Peptidoglycan Hydrolases Were Overexpressed at Transcript and Protein Levels

Although the secretome of SA113 was characterized by a high content of cytoplasmic proteins, the secretome of the atl mutant was distinguished by a predominance of secreted proteins, particularly peptidoglycan hydrolases. Of the 11 highly abundant proteins, at least 8 represented known or putative peptidoglycan hydrolases, for example the immunodominant antigen (IsaA), peptidoglycan hydrolase (LytM), autolysin precursor SA2437 (Aly), transglycosylase (SceD), and some secretory antigen precursor SsaA homolog proteins such as SsaA (SA2093), SA0620, and SA2097 (Fig. 1B and Table 3). Although these proteins have a typical SP, the elastin-binding protein (EbpS) has no SP but is described to be localized in the membrane (37). All of these proteins carry domains typical for peptidoglycan hydrolases such as Cys-His-dependent amidohydrolases/peptidases (CHAP), LysM, amidase, glucosaminidase, or transglycosidase domains (Table 4).

TABLE 3.

Proteins more abundant in the secretome of the atl mutant

Superscript F indicates fragment.

Protein Protein name Gene accession no. S. aureus N315 Gene accession no. S. aureus 8325 Molecular mass pI
kDa
Membrane proteins
    EbpSF Elastin-binding protein SA1312 01501 Fragment
    SA2103 Hypothetical protein, homolog of LytR SA2103 02583 30.8 6.8

Extracellular proteins with SP
    Hlb Truncated beta-hemolysin SA1811 02240 33.7a 7.3a
    IsaA Immunodominant antigen A SA2356 02887 21.5a 5.3a
    Lip Triacylglycerol lipase precursor SA2463 03006 72.9a 6.2a
    LytM Peptidoglycan hydrolase SA0265 00248 31.7a 6a
    SsaA Secretory antigen precursor SsaA homolog SA2093 02571 26.7a 8.7a
    SA0620 Secretory antigen SsaA homolog SA0620 00671 25.6a 5.6a
    SA0620F Secretory antigen SsaA homolog SA0620 00671 Fragment
    SA2097 Hypothetical protein, similar to secretory antigen precursor SsaA SA2097 02576 14.7a 5.1a
    SA2437 (Aly) N-Acetylmuramoyl-l-alanine amidase SA2437 02979 66.3a 5.8a
    SceD Hypothetical protein, similar to SceD precursor SA1898 02333 21.5a 5.1a

a Molecular mass and pI values were calculated for the mature protein without SP. For calculation of the theoretical SP, SignalP software was used. The localization of the proteins was predicted by PSORTb.

TABLE 4.

Genes encoding peptidoglycan hydrolase domains are up-regulated in the atl mutant

Protein Gene accession no. S. aureus N315a Protein name Domainb Transcription level
WT atl mutant
Aaa SA0423 Autolysin precursor LysM, CHAP + ++
SsaA SA2093 Secretory antigen precursor SsaA homolog CHAP + +++
Aly SA2437 N-Acetylmuramoyl-l-alanine amidase Glucosaminidase, CHAP + ++
SA2097 Hypothetical protein, similar to secretory antigen precursor SsaA CHAP + +++
SA0620 Secretory antigen SsaA homolog LysM, CHAP + ++
SA2353 Hypothetical protein, similar to secretory antigen precursor SsaA CHAP + +++
SA2332 Hypothetical protein, similar to secretory antigen precursor SsaA CHAP + +++
SA0710 Hypothetical protein, similar to secretory antigen precursor SsaA LysM, CHAP + ++
SA2100 N-Acetylmuramoyl-l-alanine amidase Glucosaminidase + ++
LytH SA1458 N-Acetylmuramoyl-l-alanine amidase Amidase + ++
IsaA SA2356 Immunodominant antigen A Transglycosylase + ++
LytM SA0265 Peptidoglycan hydrolase Peptidase + +++
SceD SA1898 Hypothetical protein Transglycosylase + +++

a Data are based on the published sequence of strain N315 (60).

b Protein domains are predicted by the on-line available annotation tool from the Sanger Institute.

The differently increased content of proteins in WT and atl mutant strains raises the question of whether the corresponding genes were transcriptionally up-regulated. Therefore, transcript amount was determined by Northern blotting at three different time points (Fig. 3 and Table 4). The transcripts for two cytoplasmic proteins GAPDH (Gap) and enolase (Eno) showed little difference in Northern blots, although these two proteins were increased in the secretome of SA113 (Figs. 1A and 3A).

FIGURE 3.

FIGURE 3.

Northern blot analyses. Cells were grown in B-medium, and total RNA was isolated after 3, 6, and 8 h of growth as indicated. Transcriptional analyses of genes encoding proteins of different cellular fractions (A) and of genes encoding secreted alternative peptidoglycan hydrolases (B) are shown.

Transcription of the hla (α-hemolysin gene), spa (protein A gene), and geh (glycerol ester hydrolases gene) were clearly repressed in the atl mutant. All three SP-containing proteins were highly abundant in the WT secretome compared with the atl mutant (Figs. 1A and 3A).

The most striking result of the transcriptional analyses was, however, that the majority of the up-regulated genes in the atl mutant encoding peptidoglycan hydrolases. These were the CHAP domain containing proteins (SA2093, SA2097, SA2353, SA0620, SA0710, SA2332, Aly, Aaa, and LytN) as well some other the alternative peptidoglycan hydrolases (SA2100, LytM, SceD, IsaA, and LytH). The Northern blots of eight alternative peptidoglycan hydrolases are shown in Fig. 3B. The up-regulation and enhanced production of these CW hydrolases suggest that the atl mutant tries to compensate for the severe defect in cell separation because of the atl mutation.

These data lead to the conclusion that there was altered expression of global regulators, which are known to control autolysis activity in S. aureus. We therefore analyzed the transcription of lrgAB, walKR, lytRS, arlRS, cidAB, and mgrA. Interestingly, none of these regulatory proteins showed differences on a transcriptional level.

GAPDH, as a Cytoplasmic Reporter Protein, Was Hardly Detectable in the Culture Supernatant of the Atl Mutant

To substantiate the results of the secretome analysis, we followed the presence of one of the cytoplasmic proteins (GAPDH) in the culture supernatants by Western blotting using α-GapA rabbit antibody (Fig. 4A). Over a time range from 2 to 48 h, GAPDH (∼36 kDa) was clearly detectable in the supernatant of SA113 and the complemented atl mutant (with atl expressing plasmid pRC14 (21)); although in all strains that lack a functional atl, it was hardly detectable. GAPDH was also excreted in 8325-4 (lacking prophages), corroborating the secretome results above, and in the spa mutant that lacks protein A, an IgG-binding protein.

FIGURE 4.

FIGURE 4.

Western blot analysis of GAPDH in the culture supernatant of various strains. A, WT (SA113), 8325-4, atl, and spa mutants; B, atl, spa, and tagO mutants; C, S. aureus (S.a.) SA113 (lane 1); S. aureus RN1 (lane 2); S. aureus HG001 (lane 3); S. aureus HG002 (lane 4); S. aureus HG003 (lane 5); S. aureus Newman (lane 6); S. aureus USA300 (lane 7); S. aureus UAMS-1 (lane 8); S. aureus COL (lane 9); S. carnosus TM300 (lane 10); and S. epidermidis O-47 (lane 11). Cells were grown in B-medium and harvested after indicated time points. GAPDH was detected with anti-GapA from rabbit. M indicates the prestained molecular weight marker.

We also were interested whether the wall teichoic acid tagO mutant has more GAPDH in the supernatant. This mutant shows an increased cell lysis because the septum-specific binding of Atl is relieved, and binding occurs all around the cell wall (22). In the tagO mutant, GAPDH was even in higher amounts in the supernatant as in the WT (Fig. 4B).

All Clinical Isolates Tested Excreted GAPDH

We also addressed the question of how widespread is the phenomenon of cytoplasmic protein excretion in S. aureus. A number of clinical isolates as well as strains differing in global regulators (38) were tested for the presence of GAPDH in the culture supernatants by Western blotting (Fig. 4C). All S. aureus strains tested excreted GAPDH. Somewhat higher amounts were present in SA113, HG001 (rsbU repaired), and HG003 (rsbU and tcaR repaired), although in USA300 GAPDH excretion appeared a bit delayed. GAPDH was also excreted in S. epidermidis O-47 and a little bit in Staphylococcus carnosus TM300.

DISCUSSION

Release of typical cytoplasmic proteins into the culture supernatant is not restricted to individual species. It has been observed in Gram-positive and -negative bacteria (S. aureus, B. subtilis, L. monocytogenes, and E. coli) and also eukaryotic cells. In particular, glycolytic enzymes, chaperones, translation factors, or enzymes involved in detoxification of reactive oxygen were found in the supernatants by secretome analysis (8, 3942). It is generally believed that these cytoplasmic proteins are simply expelled by some kind of cell lysis.

Here, we addressed the following question. What kind of cell lysis causes release of cytoplasmic proteins in S. aureus, the prophage, or the autolysin-induced cell lysis? To study this comparative secretome, analysis with S. aureus SA113, its prophage-less derivative 8325-4, and an atl mutant was carried out. First of all, it was surprising how many cytoplasmic proteins were present in the culture supernatant of the WT. The 22 cytoplasmic proteins belonged to metabolic pathway enzymes, regulators, and chaperones, as well as proteins involved in translation. However, almost the same protein pattern revealed the prophage-cured mutant 8325-4, indicating that prophages, which may trigger cell lysis upon induction with mutagens in WT (43), do not significantly contribute to the release of cytoplasmic proteins, which is in line with the findings in B. subtilis (10).

On the other hand, the secretome pattern of the atl mutant looked completely different in three respects. (a) The amount of typical cytoplasmic proteins was significantly decreased. (b) There was a pronounced predominance of alternative cell wall hydrolases with CHAP and/or LysM domains; all these proteins contain an SP and are supposed to be exported by the sec pathway. (c) The atl mutant secreted less extracellular proteases, particularly aureolysin, which was reflected by the absence of proteolytic activity on casein plates; therefore, it is unlikely that the low amount of “extracellular” cytoplasmic proteins in the atl mutant is due to proteolytic digestion.

An explanation for the decreased cytoplasmic proteins in the atl mutant could be their decreased expression. Therefore, we tested whether transcription of some of the excreted cytoplasmic proteins was decreased in the atl mutant (Fig. 3A). However, there was not much difference compared with the WT, which ruled out that decreased transcription is responsible for the decreased content in the supernatant.

By investigating GAPDH protein as a prototype of excreted cytoplasmic proteins, we could confirm in Western blots the results of the comparative two-dimensional PAGE of WT and atl mutant. In the atl mutant, GAPDH was hardly detectable in the culture supernatant over a time range of 2–48 h (Fig. 4A). If autolysis plays a crucial role in excretion of cytoplasmic proteins, then one would also expect an effect in the tagO mutant, which is characterized by an increased autolysis activity (22). Indeed, in this mutant GAPDH was even more highly abundant in the supernatant than in the WT (Fig. 4B).

We also addressed the question as to how widespread GAPDH excretion is in S. aureus. The various clinical isolates tested (38) all excreted GAPDH independent of their functional global regulators such agr, SigB, or TcaR (Fig. 4C). Interestingly, GAPDH was also excreted in S. epidermidis O-47, although in S. carnosus TM300, significantly lower amounts were detectable. The lower detection level with S. carnosus could be due to a decreased cross-reactivity of the anti-GapAS.aureus with GAPDHS.carnosus, because the two proteins have only 87% sequence identity, whereas GAPDHS.aureus and GAPDHS.epidermidis have 93% sequence identity. However, it could also mean that the nonpathogenic S. carnosus simply excretes lower amounts of cytoplasmic proteins.

An important question is how discriminatory is the excretion of cytoplasmic proteins. Are these 22 cytoplasmic proteins preferentially released because they represent the most abundant proteins in the cytoplasm? To answer this question, we performed a two-dimensional PAGE of cytoplasmic proteins isolated from SA113 (Fig. 1C). To our great surprise, quite a number of very high abundant proteins in the cytoplasm were not found in the secretome of the SA113. Two conclusions can be drawn from this observation. (a) There is no simple correlation between the quantity of cytoplasmic proteins in the cytoplasm and their release to the extracellular environment. (b) There exists a selection procedure in the excretion of cytoplasmic proteins. This brings us back to the following questions. Why do microorganisms excrete cytoplasmic proteins, which is a loss of recourses and energy? Is the excretion of such proteins an accident or is it program? If there is a program involved, one can speculate that nonfunctional (e.g. misfolded) cytoplasmic proteins are recognized and withdrawn by excretion. For example, E. coli enolase was only excreted when it was covalently modified by its substrate 2-phosphoglycerate (44), suggesting a selective and specific export system. Furthermore, it has been observed in a prsA foldase mutant in B. subtilis that the number of nonclassically secreted proteins was increased (45); however, as in this mutant cell lysis was also increased, it is not certain whether this was due to the increase of misfolded proteins. On the other hand, one could argue that the enhanced cell lysis is a rescue program to get rid of misfolded and therefore dangerous proteins.

As Atl binds preferentially at the septum site, we assume that the proteins are preferentially released at and during septum formation. This is the site with the highest CW biosynthetic activity and binding site of Atl where it resolves the interlinked murein layers of the daughter cells (22, 46). Therefore, the septum region could be the leaky site for cytoplasmic protein excretion.

Another mechanism for excretion of cytoplasmic proteins could be their release by membrane vesicles (MVs). In Gram-negative as well as in Gram-positive bacteria, it has been shown that in such MVs cytoplasmic proteins like GAPDH, PdhB, EF-Tu, RpsB, and GroEL can be transported to the medium (4749). Indeed, in transmission electron microscopic images of staphylococcal strains during autolysis and particularly in the tagO mutant (22), one can see pleb-like structures on the cell surface that might be MVs. However, the list of proteins identified from S. aureus-derived MVs mentions 91 proteins of cytoplasmic, membrane, and secreted origin (48), which implies little specificity in contrast to our results. But it is quite possible that MVs and autolysis are somehow connected.

CONCLUSION

This study shows that the major autolysin plays a crucial role in excretion of cytoplasmic proteins. Although such an excretion/release by autolysis implies little differentiation, our results suggest the existence of a selection procedure. There are still many questions open, such as the selectivity and the site of excretion, and more detailed knowledge regarding its mechanism is needed.

Supplementary Material

Supplemental Data

Acknowledgments

We thank Regine Stemmler, Silke Wahl, and Inga Buchen for excellent technical assistance and the Ministerium für Wissenschaft und Kunst and the Landesstiftung Baden-Württemberg for financial support of the Proteome Center Tübingen.

*

This work was supported by the Deutsche Forschungsgemeinschaft, SFB 766, and Graduate College Grant GKI 685.

Inline graphic

The on-line version of this article (available at http://www.jbc.org) contains supplemental Table 1 and Fig. 1.

2
The abbreviations used are:
SP
signal peptide
Atl
major autolysin
CW
cell wall
CHAP
Cys-His-dependent amidohydrolases/peptidases
MV
membrane vesicle.

REFERENCES

  • 1.Fuchs S., Pané-Farré J., Kohler C., Hecker M., Engelmann S. (2007) J. Bacteriol. 189, 4275–4289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Resch A., Leicht S., Saric M., Pásztor L., Jakob A., Götz F., Nordheim A. (2006) Proteomics 6, 1867–1877 [DOI] [PubMed] [Google Scholar]
  • 3.Kohler C., Wolff S., Albrecht D., Fuchs S., Becher D., Büttner K., Engelmann S., Hecker M. (2005) Int. J. Med. Microbiol. 295, 547–565 [DOI] [PubMed] [Google Scholar]
  • 4.Chatterjee I., Schmitt S., Batzilla C. F., Engelmann S., Keller A., Ring M. W., Kautenburger R., Ziebuhr W., Hecker M., Preissner K. T., Bischoff M., Proctor R. A., Beck H. P., Lenhof H. P., Somerville G. A., Herrmann M. (2009) Proteomics 9, 1152–1176 [DOI] [PubMed] [Google Scholar]
  • 5.Ziebandt A. K., Becher D., Ohlsen K., Hacker J., Hecker M., Engelmann S. (2004) Proteomics 4, 3034–3047 [DOI] [PubMed] [Google Scholar]
  • 6.Ziebandt A. K., Weber H., Rudolph J., Schmid R., Höper D., Engelmann S., Hecker M. (2001) Proteomics 1, 480–493 [DOI] [PubMed] [Google Scholar]
  • 7.Sibbald M. J., Winter T., van der Kooi-Pol M. M., Buist G., Tsompanidou E., Bosma T., Schafer T., Ohlsen K., Hecker M., Antelmann H., Engelmann S., van Dijl J. M. (2010) J. Bacteriol. 192, 3788–3800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tjalsma H., Antelmann H., Jongbloed J. D., Braun P. G., Darmon E., Dorenbos R., Dubois J. Y., Westers H., Zanen G., Quax W. J., Kuipers O. P., Bron S., Hecker M., van Dijl J. M. (2004) Microbiol. Mol. Biol. Rev. 68, 207–233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Young R., Bläsi U. (1995) FEMS Microbiol. Rev. 17, 191–205 [DOI] [PubMed] [Google Scholar]
  • 10.Westers H., Dorenbos R., van Dijl J. M., Kabel J., Flanagan T., Devine K. M., Jude F., Seror S. J., Beekman A. C., Darmon E., Eschevins C., de Jong A., Bron S., Kuipers O. P., Albertini A. M., Antelmann H., Hecker M., Zamboni N., Sauer U., Bruand C., Ehrlich D. S., Alonso J. C., Salas M., Quax W. J. (2003) Mol. Biol. Evol. 20, 2076–2090 [DOI] [PubMed] [Google Scholar]
  • 11.Walker S. A., Klaenhammer T. R. (2001) Appl. Environ. Microbiol. 67, 251–259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Büttner K., Bernhardt J., Scharf C., Schmid R., Mäder U., Eymann C., Antelmann H., Völker A., Völker U., Hecker M. (2001) Electrophoresis 22, 2908–2935 [DOI] [PubMed] [Google Scholar]
  • 13.Burts M. L., DeDent A. C., Missiakas D. M. (2008) Mol. Microbiol. 69, 736–746 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Biswas L., Biswas R., Nerz C., Ohlsen K., Schlag M., Schäfer T., Lamkemeyer T., Ziebandt A. K., Hantke K., Rosenstein R., Götz F. (2009) J. Bacteriol. 191, 5921–5929 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Otto M., Peschel A., Götz F. (1998) FEMS Microbiol. Lett. 166, 203–211 [DOI] [PubMed] [Google Scholar]
  • 16.Otto M., Götz F. (2001) Res. Microbiol. 152, 351–356 [DOI] [PubMed] [Google Scholar]
  • 17.Bendtsen J. D., Kiemer L., Fausbøll A., Brunak S. (2005) BMC Microbiol. 5, 58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Iandolo J. J., Worrell V., Groicher K. H., Qian Y., Tian R., Kenton S., Dorman A., Ji H., Lin S., Loh P., Qi S., Zhu H., Roe B. A. (2002) Gene 289, 109–118 [DOI] [PubMed] [Google Scholar]
  • 19.Novick R. (1967) Virology 33, 155–166 [DOI] [PubMed] [Google Scholar]
  • 20.Oshida T., Sugai M., Komatsuzawa H., Hong Y. M., Suginaka H., Tomasz A. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 285–289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Heilmann C., Hussain M., Peters G., Götz F. (1997) Mol. Microbiol. 24, 1013–1024 [DOI] [PubMed] [Google Scholar]
  • 22.Schlag M., Biswas R., Krismer B., Kohler T., Zoll S., Yu W., Schwarz H., Peschel A., Götz F. (2010) Mol. Microbiol. 75, 864–873 [DOI] [PubMed] [Google Scholar]
  • 23.Biswas R., Voggu L., Simon U. K., Hentschel P., Thumm G., Götz F. (2006) FEMS Microbiol. Lett. 259, 260–268 [DOI] [PubMed] [Google Scholar]
  • 24.Zoll S., Pätzold B., Schlag M., Götz F., Kalbacher H., Stehle T. (2010) PLoS Pathog. 6, e1000807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Rupp M. E., Fey P. D., Heilmann C., Götz F. (2001) J. Infect Dis. 183, 1038–1042 [DOI] [PubMed] [Google Scholar]
  • 26.Kohler C., von Eiff C., Liebeke M., McNamara P. J., Lalk M., Proctor R. A., Hecker M., Engelmann S. (2008) J. Bacteriol. 190, 6351–6364 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bradford M. M. (1976) Anal. Biochem. 72, 248–254 [DOI] [PubMed] [Google Scholar]
  • 28.Becher D., Hempel K., Sievers S., Zühlke D., Pané-Farré J., Otto A., Fuchs S., Albrecht D., Bernhardt J., Engelmann S., Völker U., van Dijl J. M., Hecker M. (2009) PLoS One 4, e8176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Eymann C., Dreisbach A., Albrecht D., Bernhardt J., Becher D., Gentner S., Tam le T., Büttner K., Buurman G., Scharf C., Venz S., Völker U., Hecker M. (2004) Proteomics 4, 2849–2876 [DOI] [PubMed] [Google Scholar]
  • 30.Candiano G., Bruschi M., Musante L., Santucci L., Ghiggeri G. M., Carnemolla B., Orecchia P., Zardi L., Righetti P. G. (2004) Electrophoresis 25, 1327–1333 [DOI] [PubMed] [Google Scholar]
  • 31.Hála M., Cole R., Synek L., Drdová E., Pecenková T., Nordheim A., Lamkemeyer T., Madlung J., Hochholdinger F., Fowler J. E., Zárský V. (2008) Plant Cell 20, 1330–1345 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Gertz S., Engelmann S., Schmid R., Ohlsen K., Hacker J., Hecker M. (1999) Mol. Gen. Genet. 261, 558–566 [DOI] [PubMed] [Google Scholar]
  • 33.Majumdar D., Avissar Y. J., Wyche J. H. (1991) BioTechniques 11, 94–101 [PubMed] [Google Scholar]
  • 34.Schägger H., von Jagow G. (1987) Anal. Biochem. 166, 368–379 [DOI] [PubMed] [Google Scholar]
  • 35.Zell C., Resch M., Rosenstein R., Albrecht T., Hertel C., Götz F. (2008) Int. J. Food Microbiol. 127, 246–251 [DOI] [PubMed] [Google Scholar]
  • 36.Taylor J. M., Heinrichs D. E. (2002) Mol. Microbiol. 43, 1603–1614 [DOI] [PubMed] [Google Scholar]
  • 37.Downer R., Roche F., Park P. W., Mecham R. P., Foster T. J. (2002) J. Biol. Chem. 277, 243–250 [DOI] [PubMed] [Google Scholar]
  • 38.Herbert S., Ziebandt A. K., Ohlsen K., Schäfer T., Hecker M., Albrecht D., Novick R., Götz F. (2010) Infect. Immun. 78, 2877–2889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Sibbald M. J., Ziebandt A. K., Engelmann S., Hecker M., de Jong A., Harmsen H. J., Raangs G. C., Stokroos I., Arends J. P., Dubois J. Y., van Dijl J. M. (2006) Microbiol. Mol. Biol. Rev. 70, 755–788 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Trost M., Wehmhöner D., Kärst U., Dieterich G., Wehland J., Jänsch L. (2005) Proteomics 5, 1544–1557 [DOI] [PubMed] [Google Scholar]
  • 41.Xia X. X., Han M. J., Lee S. Y., Yoo J. S. (2008) Proteomics 8, 2089–2103 [DOI] [PubMed] [Google Scholar]
  • 42.Li M., Rosenshine I., Tung S. L., Wang X. H., Friedberg D., Hew C. L., Leung K. Y. (2004) Appl. Environ. Microbiol. 70, 5274–5282 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Resch A., Fehrenbacher B., Eisele K., Schaller M., Götz F. (2005) FEMS Microbiol. Lett. 252, 89–96 [DOI] [PubMed] [Google Scholar]
  • 44.Boël G., Pichereau V., Mijakovic I., Mazé A., Poncet S., Gillet S., Giard J. C., Hartke A., Auffray Y., Deutscher J. (2004) J. Mol. Biol. 337, 485–496 [DOI] [PubMed] [Google Scholar]
  • 45.Vitikainen M., Lappalainen I., Seppala R., Antelmann H., Boer H., Taira S., Savilahti H., Hecker M., Vihinen M., Sarvas M., Kontinen V. P. (2004) J. Biol. Chem. 279, 19302–19314 [DOI] [PubMed] [Google Scholar]
  • 46.Yamada S., Sugai M., Komatsuzawa H., Nakashima S., Oshida T., Matsumoto A., Suginaka H. (1996) J. Bacteriol. 178, 1565–1571 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lee E. Y., Choi D. S., Kim K. P., Gho Y. S. (2008) Mass Spectrom. Rev. 27, 535–555 [DOI] [PubMed] [Google Scholar]
  • 48.Lee E. Y., Choi D. Y., Kim D. K., Kim J. W., Park J. O., Kim S., Kim S. H., Desiderio D. M., Kim Y. K., Kim K. P., Gho Y. S. (2009) Proteomics 9, 5425–5436 [DOI] [PubMed] [Google Scholar]
  • 49.Deatherage B. L., Lara J. C., Bergsbaken T., Rassoulian Barrett S. L., Lara S., Cookson B. T. (2009) Mol. Microbiol. 72, 1395–1407 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Iordanescu S., Surdeanu M. (1976) J. Gen. Microbiol. 96, 277–281 [DOI] [PubMed] [Google Scholar]
  • 51.Heilmann C., Schweitzer O., Gerke C., Vanittanakom N., Mack D., Götz F. (1996) Mol. Microbiol. 20, 1083–1091 [DOI] [PubMed] [Google Scholar]
  • 52.Weidenmaier C., Kokai-Kun J. F., Kristian S. A., Chanturiya T., Kalbacher H., Gross M., Nicholson G., Neumeister B., Mond J. J., Peschel A. (2004) Nat. Med. 10, 243–245 [DOI] [PubMed] [Google Scholar]
  • 53.Novick R. P., Ross H. F., Projan S. J., Kornblum J., Kreiswirth B., Moghazeh S. (1993) EMBO J. 12, 3967–3975 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Duthie E. S. (1952) J. Gen. Microbiol. 7, 320–326 [DOI] [PubMed] [Google Scholar]
  • 55.McDougal L. K., Steward C. D., Killgore G. E., Chaitram J. M., McAllister S. K., Tenover F. C. (2003) J. Clin. Microbiol. 41, 5113–5120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Gillaspy A. F., Hickmon S. G., Skinner R. A., Thomas J. R., Nelson C. L., Smeltzer M. S. (1995) Infect. Immun. 63, 3373–3380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Dyke K. G., Jevons M. P., Parker M. T. (1966) Lancet 1, 835–838 [DOI] [PubMed] [Google Scholar]
  • 58.Schleifer K. H. (1982) Int. J. Syst. Bacteriol. 32, 153–156 [Google Scholar]
  • 59.Heilmann C., Gerke C., Perdreau-Remington F., Götz F. (1996) Infect. Immun. 64, 277–282 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I., Cui L., Oguchi A., Aoki K., Nagai Y., Lian J., Ito T., Kanamori M., Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y., Takahashi N. K., Sawano T., Inoue R., Kaito C., Sekimizu K., Hirakawa H., Kuhara S., Goto S., Yabuzaki J., Kanehisa M., Yamashita A., Oshima K., Furuya K., Yoshino C., Shiba T., Hattori M., Ogasawara N., Hayashi H., Hiramatsu K. (2001) Lancet 357, 1225–1240 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES